RNVA Company Profile and Key Details

The stock is currently trading near its 52-week high $0.00 and $0.00. With a market capitalization of about $4.31 million, Rennova Health, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.05). Key stats such as the average daily volume over the past year has been around 799.51 thousand shares, volume is running light vs its 52-week average. Headquartered in West Palm Beach, FL, Rennova Health, Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Seamus Lagan, the company employs approximately 96 people and listed since October 19, 1995. Rennova Health, Inc., through its various subsidiaries, provides medical services throughout the United States.

Average 10-day trading volume of 495.05 thousand shares is below the 3-month average of 808.63 thousand, indicating normal recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Our AI price prediction model suggests that Rennova Health, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Rennova Health, Inc. trading at a premium to the broader market with a P/E of -0.5.

Rennova Health, Inc. trades at a P/E ratio of -0.5, slightly below the S&P 500 average, with a price-to-sales ratio of 0.23 and a price-to-book ratio of -0.09 indicating negative book value, which may reflect financial stress. The P/FCF stands at 1.42, also above market averages.